We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+6.61%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$2.02B
AUM Growth
+$513M
Cap. Flow
+$460M
Cap. Flow %
22.74%
Top 10 Hldgs %
21.5%
Holding
481
New
197
Increased
58
Reduced
57
Closed
164

Sector Composition

Rank Sector Weight
1 Technology 7.95%
2 Industrials 7.82%
3 Consumer Discretionary 5.99%
4 Communication Services 5.9%
5 Consumer Staples 3.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMD icon
201
PUT
Advanced Micro Devices
AMD
$851B
$2.18M 0.11%
+150,000
New +$1.9M
FFIV icon
202
PUT
F5
FFIV
$22.1B
$2.14M 0.11%
+15,000
New +$2.14M
AEO icon
203
CALL
American Eagle Outfitters
AEO
$2.85B
$2.1M 0.1%
150,000
-375,200
-71% -$5.58M
CTRA
204
DELISTED
Coterra Energy
CTRA
$2.09M 0.1%
87,268
+53,468
+158% +$1.21M
CMCSA icon
205
PUT
Comcast
CMCSA
$79.1B
$2.07M 0.1%
+55,000
New +$2.04M
NBIX icon
206
Neurocrine Biosciences
NBIX
$17.7B
$2.02M 0.1%
+46,700
New +$2M
GPK icon
207
Graphic Packaging
GPK
$3.26B
$2.02M 0.1%
157,000
+57,000
+57% +$741K
TXN icon
208
PUT
Texas Instruments
TXN
$255B
$2.01M 0.1%
+25,000
New +$1.94M
MRO
209
DELISTED
Marathon Oil Corporation
MRO
$1.95M 0.1%
+123,600
New +$2.03M
PBYI icon
210
CALL
Puma Biotechnology
PBYI
$406M
$1.93M 0.1%
+52,000
New +$1.9M
FMC icon
211
FMC
FMC
$1.42B
$1.93M 0.1%
31,996
-26,980
-46% -$1.4M
VIAV icon
212
CALL
Viavi Solutions
VIAV
$9.75B
$1.93M 0.1%
+180,000
New +$1.75M
HIMX
213
Himax Technologies
HIMX
$2.2B
$1.79M 0.09%
+196,500
New +$1.33M
BABA icon
214
Alibaba
BABA
$269B
$1.78M 0.09%
+16,500
New +$1.68M
AVXS
215
DELISTED
AveXis, Inc. Common Stock
AVXS
$1.75M 0.09%
+23,000
New +$1.42M
GBX icon
216
PUT
The Greenbrier Companies
GBX
$1.61B
$1.72M 0.09%
+40,000
New +$1.77M
IMMU
217
CALL
DELISTED
Immunomedics Inc
IMMU
$1.68M 0.08%
260,000
-130,000
-33% -$659K
CLR
218
DELISTED
CONTINENTAL RESOURCES INC.
CLR
$1.64M 0.08%
36,086
+16,286
+82% +$767K
CLVS
219
DELISTED
Clovis Oncology, Inc.
CLVS
$1.64M 0.08%
+25,700
New +$1.56M
RIGL icon
220
Rigel Pharmaceuticals
RIGL
$680M
$1.64M 0.08%
49,400
-28,700
-37% -$731K
QEP
221
DELISTED
QEP RESOURCES, INC.
QEP
$1.61M 0.08%
+127,100
New +$2M
GS icon
222
CALL
Goldman Sachs
GS
$313B
$1.61M 0.08%
+7,000
New +$1.69M
LUMO
223
CALL
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$1.57M 0.08%
+7,222
New +$1.03M
GDX icon
224
VanEck Gold Miners ETF
GDX
$23B
$1.56M 0.08%
68,400
-8,300
-11% -$193K
BLUE
225
DELISTED
bluebird bio
BLUE
$1.53M 0.08%
+1,297
New +$1.32M

Similar funds

J. Goldman & Co's Q1 2017 Portfolio in Review

As of Q1 2017, J. Goldman & Co held 481 positions worth $2.02B, up 34% from $1.51B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

J. Goldman & Co deployed $460M of net new capital in Q1 2017, opening 197 new positions and adding to 58 existing holdings. Its largest new stake was Time Warner Inc: 345,000 shares worth $33.7M.

By sector, the portfolio is most concentrated in Technology at 7.9% of assets, up from 6.7% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was CSX Corp, an estimated $13.1M trimmed.

  • J. Goldman & Co's largest Q1 2017 buy was Time Warner Inc: 345,000 shares worth $33.7M.
  • J. Goldman & Co added most to NXP Semiconductors in Q1 2017, an estimated $17.2M increase.
  • J. Goldman & Co's biggest Q1 2017 reduction was CSX Corp, cutting an estimated $13.1M.
  • J. Goldman & Co fully exited Bath & Body Works in Q1 2017, selling an estimated $27.4M.
  • J. Goldman & Co's ten largest holdings make up 22% of its $2.02B portfolio in Q1 2017.
  • J. Goldman & Co opened 197 new positions and closed 164 in Q1 2017.
  • J. Goldman & Co's portfolio value rose 34% quarter-over-quarter to $2.02B.

Based on J. Goldman & Co's 13F filing for Q1 2017, filed 15 May 2017.